APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastritis Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gastritis Treatment Drugs Market Outlook and Growth Opportunities 2026

20 December 2025191 pages

Choose your research edition.

Industry ResearchGastritis Treatment Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastritis Treatment Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Gastritis Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastritis Treatment Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastritis Treatment Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Gastritis Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gastritis Treatment Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gastritis Treatment Drugs market include Sun Pharmaceutical Industries, Novartis, Pfizer, AstraZeneca, Reddy's Laboratories, Perrigo Pharmaceutical, Microbiotix, Lupin Ltd and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastritis Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastritis Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastritis Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastritis Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastritis Treatment Drugs Segment by Company

Sun Pharmaceutical Industries

Novartis

Pfizer

AstraZeneca

Reddy's Laboratories

Perrigo Pharmaceutical

Microbiotix

Lupin Ltd

Cipla

Abbott Laboratories

Gastritis Treatment Drugs Segment by Type

Antibiotics

Antacids

Acid-Blocking Medicines

Histamine Blockers

Others

Gastritis Treatment Drugs Segment by Application

Hospitals

Clinics

Others

Gastritis Treatment Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gastritis Treatment Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gastritis Treatment Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gastritis Treatment Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Gastritis Treatment Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastritis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastritis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastritis Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastritis Treatment Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastritis Treatment Drugs industry.

Chapter 3: Detailed analysis of Gastritis Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gastritis Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gastritis Treatment Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gastritis Treatment Drugs Industry Trends Table 2. Gastritis Treatment Drugs Industry Drivers Table 3. Gastritis Treatment Drugs Industry Opportunities and Challenges Table 4. Gastritis Treatment Drugs Industry Restraints Table 5. Global Gastritis Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gastritis Treatment Drugs Revenue Share by Company (2021-2026) Table 7. Global Gastritis Treatment Drugs Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Gastritis Treatment Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Gastritis Treatment Drugs Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Gastritis Treatment Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gastritis Treatment Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Gastritis Treatment Drugs Company, Product Type & Application Table 13. Global Gastritis Treatment Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastritis Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antibiotics Table 18. Significant Companies of Antacids Table 19. Significant Companies of Acid-Blocking Medicines Table 20. Significant Companies of Histamine Blockers Table 21. Significant Companies of Others Table 22. Global Gastritis Treatment Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 23. Global Gastritis Treatment Drugs Sales Volume by Type (2021-2026) & (W Tons) Table 24. Global Gastritis Treatment Drugs Sales Volume by Type (2027-2032) & (W Tons) Table 25. Global Gastritis Treatment Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Gastritis Treatment Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Gastritis Treatment Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gastritis Treatment Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Gastritis Treatment Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Gastritis Treatment Drugs Sales Value Share by Type (2021-2026) Table 31. Global Gastritis Treatment Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Clinics Table 34. Significant Companies of Others Table 35. Global Gastritis Treatment Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 36. Global Gastritis Treatment Drugs Sales Volume by Application (2021-2026) & (W Tons) Table 37. Global Gastritis Treatment Drugs Sales Volume by Application (2027-2032) & (W Tons) Table 38. Global Gastritis Treatment Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Gastritis Treatment Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Gastritis Treatment Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Gastritis Treatment Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Gastritis Treatment Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Gastritis Treatment Drugs Sales Value Share by Application (2021-2026) Table 44. Global Gastritis Treatment Drugs Sales Value Share by Application (2027-2032) Table 45. Global Gastritis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 46. Global Gastritis Treatment Drugs Sales by Region (2021-2026) & (W Tons) Table 47. Global Gastritis Treatment Drugs Sales Market Share by Region (2021-2026) Table 48. Global Gastritis Treatment Drugs Sales by Region (2027-2032) & (W Tons) Table 49. Global Gastritis Treatment Drugs Sales Market Share by Region (2027-2032) Table 50. Global Gastritis Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Gastritis Treatment Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Gastritis Treatment Drugs Sales Value Share by Region (2021-2026) Table 53. Global Gastritis Treatment Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Gastritis Treatment Drugs Sales Value Share by Region (2027-2032) Table 55. Global Gastritis Treatment Drugs Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Gastritis Treatment Drugs Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 58. Global Gastritis Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Gastritis Treatment Drugs Sales by Country (2021-2026) & (W Tons) Table 60. Global Gastritis Treatment Drugs Sales Market Share by Country (2021-2026) Table 61. Global Gastritis Treatment Drugs Sales by Country (2027-2032) & (W Tons) Table 62. Global Gastritis Treatment Drugs Sales Market Share by Country (2027-2032) Table 63. Global Gastritis Treatment Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Gastritis Treatment Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Gastritis Treatment Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Gastritis Treatment Drugs Sales Value Market Share by Country (2027-2032) Table 67. Sun Pharmaceutical Industries Company Information Table 68. Sun Pharmaceutical Industries Business Overview Table 69. Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio Table 71. Sun Pharmaceutical Industries Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Novartis Gastritis Treatment Drugs Product Portfolio Table 76. Novartis Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Pfizer Gastritis Treatment Drugs Product Portfolio Table 81. Pfizer Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. AstraZeneca Gastritis Treatment Drugs Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Reddy's Laboratories Company Information Table 88. Reddy's Laboratories Business Overview Table 89. Reddy's Laboratories Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio Table 91. Reddy's Laboratories Recent Development Table 92. Perrigo Pharmaceutical Company Information Table 93. Perrigo Pharmaceutical Business Overview Table 94. Perrigo Pharmaceutical Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio Table 96. Perrigo Pharmaceutical Recent Development Table 97. Microbiotix Company Information Table 98. Microbiotix Business Overview Table 99. Microbiotix Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Microbiotix Gastritis Treatment Drugs Product Portfolio Table 101. Microbiotix Recent Development Table 102. Lupin Ltd Company Information Table 103. Lupin Ltd Business Overview Table 104. Lupin Ltd Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Lupin Ltd Gastritis Treatment Drugs Product Portfolio Table 106. Lupin Ltd Recent Development Table 107. Cipla Company Information Table 108. Cipla Business Overview Table 109. Cipla Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Cipla Gastritis Treatment Drugs Product Portfolio Table 111. Cipla Recent Development Table 112. Abbott Laboratories Company Information Table 113. Abbott Laboratories Business Overview Table 114. Abbott Laboratories Gastritis Treatment Drugs Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Abbott Laboratories Gastritis Treatment Drugs Product Portfolio Table 116. Abbott Laboratories Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Gastritis Treatment Drugs Distributors List Table 120. Gastritis Treatment Drugs Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Gastritis Treatment Drugs Product Image Figure 2. Global Gastritis Treatment Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gastritis Treatment Drugs Sales (2021-2032) & (W Tons) Figure 5. Global Gastritis Treatment Drugs Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Gastritis Treatment Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antibiotics Image Figure 10. Antacids Image Figure 11. Acid-Blocking Medicines Image Figure 12. Histamine Blockers Image Figure 13. Others Image Figure 14. Global Gastritis Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Gastritis Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Gastritis Treatment Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Gastritis Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Gastritis Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Gastritis Treatment Drugs Sales Value Share by Type (2021-2032) Figure 20. Hospitals Image Figure 21. Clinics Image Figure 22. Others Image Figure 23. Global Gastritis Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Gastritis Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Gastritis Treatment Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Gastritis Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Gastritis Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Gastritis Treatment Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Gastritis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 30. Global Gastritis Treatment Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Gastritis Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Gastritis Treatment Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Gastritis Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Gastritis Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Gastritis Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Gastritis Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Gastritis Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Gastritis Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Gastritis Treatment Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Gastritis Treatment Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antacids
  • Acid-Blocking Medicines
  • Histamine Blockers
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Pfizer
  • AstraZeneca
  • Reddy's Laboratories
  • Perrigo Pharmaceutical
  • Microbiotix
  • Lupin Ltd
  • Cipla
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastritis Treatment Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Gastritis Treatment Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Gastritis Treatment Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gastritis Treatment Drugs Market Dynamics
  1. 2.1 Gastritis Treatment Drugs Industry Trends
  2. 2.2 Gastritis Treatment Drugs Industry Drivers
  3. 2.3 Gastritis Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Gastritis Treatment Drugs Industry Restraints
3 Gastritis Treatment Drugs Market by Company
  1. 3.1 Global Gastritis Treatment Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Gastritis Treatment Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Gastritis Treatment Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Gastritis Treatment Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Gastritis Treatment Drugs Company Ranking (2024-2026)
  6. 3.6 Global Gastritis Treatment Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Gastritis Treatment Drugs Company Product Type and Application
  8. 3.8 Global Gastritis Treatment Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gastritis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gastritis Treatment Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gastritis Treatment Drugs Market by Type
  1. 4.1 Gastritis Treatment Drugs Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Antacids
  4. 4.1.3 Acid-Blocking Medicines
  5. 4.1.4 Histamine Blockers
  6. 4.1.5 Others
  7. 4.2 Global Gastritis Treatment Drugs Sales Volume by Type
  8. 4.2.1 Global Gastritis Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Gastritis Treatment Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Gastritis Treatment Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Gastritis Treatment Drugs Sales Value by Type
  12. 4.3.1 Global Gastritis Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Gastritis Treatment Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Gastritis Treatment Drugs Sales Value Share by Type (2021-2032)
5 Gastritis Treatment Drugs Market by Application
  1. 5.1 Gastritis Treatment Drugs Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Gastritis Treatment Drugs Sales Volume by Application
  6. 5.2.1 Global Gastritis Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastritis Treatment Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gastritis Treatment Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gastritis Treatment Drugs Sales Value by Application
  10. 5.3.1 Global Gastritis Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gastritis Treatment Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gastritis Treatment Drugs Sales Value Share by Application (2021-2032)
6 Gastritis Treatment Drugs Regional Sales and Value Analysis
  1. 6.1 Global Gastritis Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastritis Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gastritis Treatment Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Gastritis Treatment Drugs Sales by Region (2027-2032)
  5. 6.3 Global Gastritis Treatment Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gastritis Treatment Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gastritis Treatment Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gastritis Treatment Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Gastritis Treatment Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gastritis Treatment Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Gastritis Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gastritis Treatment Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Gastritis Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gastritis Treatment Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gastritis Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gastritis Treatment Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Gastritis Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gastritis Treatment Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gastritis Treatment Drugs Sales Value Share by Country, 2025 VS 2032
7 Gastritis Treatment Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Gastritis Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gastritis Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gastritis Treatment Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Gastritis Treatment Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Gastritis Treatment Drugs Sales by Country (2027-2032)
  6. 7.4 Global Gastritis Treatment Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gastritis Treatment Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gastritis Treatment Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gastritis Treatment Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gastritis Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gastritis Treatment Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries
  2. 8.1.1 Sun Pharmaceutical Industries Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Gastritis Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Gastritis Treatment Drugs Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Gastritis Treatment Drugs Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Reddy's Laboratories
  26. 8.5.1 Reddy's Laboratories Company Information
  27. 8.5.2 Reddy's Laboratories Business Overview
  28. 8.5.3 Reddy's Laboratories Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio
  30. 8.5.5 Reddy's Laboratories Recent Developments
  31. 8.6 Perrigo Pharmaceutical
  32. 8.6.1 Perrigo Pharmaceutical Company Information
  33. 8.6.2 Perrigo Pharmaceutical Business Overview
  34. 8.6.3 Perrigo Pharmaceutical Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio
  36. 8.6.5 Perrigo Pharmaceutical Recent Developments
  37. 8.7 Microbiotix
  38. 8.7.1 Microbiotix Company Information
  39. 8.7.2 Microbiotix Business Overview
  40. 8.7.3 Microbiotix Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Microbiotix Gastritis Treatment Drugs Product Portfolio
  42. 8.7.5 Microbiotix Recent Developments
  43. 8.8 Lupin Ltd
  44. 8.8.1 Lupin Ltd Company Information
  45. 8.8.2 Lupin Ltd Business Overview
  46. 8.8.3 Lupin Ltd Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Ltd Gastritis Treatment Drugs Product Portfolio
  48. 8.8.5 Lupin Ltd Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Gastritis Treatment Drugs Product Portfolio
  54. 8.9.5 Cipla Recent Developments
  55. 8.10 Abbott Laboratories
  56. 8.10.1 Abbott Laboratories Company Information
  57. 8.10.2 Abbott Laboratories Business Overview
  58. 8.10.3 Abbott Laboratories Gastritis Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Laboratories Gastritis Treatment Drugs Product Portfolio
  60. 8.10.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastritis Treatment Drugs Value Chain Analysis
  2. 9.1.1 Gastritis Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastritis Treatment Drugs Sales Mode & Process
  6. 9.2 Gastritis Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastritis Treatment Drugs Distributors
  9. 9.2.3 Gastritis Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst